Catalyst Wire Dossier Catalyst Wire Dossier

PANRETIN

ALITRETINOIN · Advanz Pharma (US) Corp.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PANRETIN, covering 2013-11-22 to 2025-11-17. Get the full timeline:

Most recent: FDA Approved: PANRETIN — Supplemental Application (Advanz Pharma (US) Corp.)

See pricing